BGF World Healthscience A2 AUD H/ LU1023059063 /
| NAV7/1/2022 | Chg.+0.0800 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 20.2400AUD | +0.40% | reinvestment | Equity Worldwide | BlackRock (LU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014 | - | - | -4.47 | -0.94 | 2.62 | 3.99 | 0.39 | 3.43 | 0.95 | 4.60 | 3.86 | -0.43 | - |
| 2015 | 1.82 | 4.00 | 2.54 | -0.88 | 3.79 | -0.70 | 3.67 | -6.03 | -8.91 | 6.70 | -0.08 | 1.49 | +6.50% |
| 2016 | -10.42 | -0.27 | 1.55 | 4.22 | 2.41 | -0.50 | 5.41 | -3.21 | -0.66 | -6.26 | 1.25 | 0.09 | -7.25% |
| 2017 | 1.67 | 7.43 | 0.48 | 2.48 | 1.48 | 3.62 | 0.15 | -0.30 | 1.12 | -0.15 | 2.06 | 0.51 | +22.30% |
| 2018 | 6.17 | -4.19 | -3.67 | 2.34 | 1.86 | 1.34 | 4.16 | 4.06 | 2.56 | -6.18 | 4.26 | -7.53 | +4.09% |
| 2019 | 4.62 | 3.10 | 0.06 | -3.19 | -1.78 | 6.92 | 1.95 | -0.31 | -1.61 | 4.59 | 4.21 | 2.83 | +22.97% |
| 2020 | -0.34 | -8.72 | -3.88 | 11.29 | 3.63 | -1.56 | 5.82 | 1.23 | -1.42 | -5.08 | 8.06 | 3.60 | +11.39% |
| 2021 | 1.66 | -2.58 | 1.32 | 4.72 | 0.96 | 2.42 | 1.90 | 1.73 | -4.52 | 2.01 | -2.48 | 6.07 | +13.49% |
| 2022 | -8.30 | -0.58 | 5.94 | -3.67 | -1.67 | -2.23 | 0.40 | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 19.37% | 19.45% | 15.78% | 17.09% | 15.65% |
| Sharpe ratio | -0.99 | -0.85 | -0.42 | 0.48 | 0.55 |
| Best month | +6.07% | +5.94% | +6.07% | +11.29% | +11.29% |
| Worst month | -8.30% | -8.30% | -8.30% | -8.72% | -8.72% |
| Maximum loss | -16.55% | -15.91% | -16.59% | -27.14% | -27.14% |
| Outperformance | -5.56% | - | +0.96% | +4.52% | +5.67% |
All quotes in AUD
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| BGF World Healthscience A2 AUD H | reinvestment | 20.2400 | -6.77% | +25.79% | |
| BGF World Healthscience A2 HKD H | reinvestment | 208.1500 | -6.11% | +30.53% | |
| BGF World Healthscience A2 SGD H | reinvestment | 20.6600 | -6.01% | +28.80% | |
| BGF World Healthscience C2 EUR | reinvestment | 45.1300 | +6.26% | +37.68% | |
| BGF World Healthscience A2 CNH H | reinvestment | 178.8500 | -3.94% | +37.30% | |
| BGF World Healthscience D2 USD | reinvestment | 67.8000 | -5.06% | +34.26% | |
| BGF World Healthscience D2 EUR | reinvestment | 65.1900 | +8.43% | +46.20% | |
| BGF World Healthscience D4 EUR | paying dividend | 15.4600 | -5.04% | +34.26% | |
| BGF World Healthscience X2 USD | reinvestment | 75.8100 | -4.12% | +38.31% | |
| BGF World Healthscience E2 USD | reinvestment | 54.6500 | -6.24% | +29.32% | |
| BGF World Healthscience A4 EUR | paying dividend | 11.0100 | +7.52% | - | |
| BGF World Healthscience A4 USD | paying dividend | 11.4600 | -5.76% | - | |
| BGF World Healthscience A2 EUR H | reinvestment | 13.6900 | -7.12% | +24.68% | |
| BGF World Healthscience E2 EUR | reinvestment | 52.5400 | +7.07% | +40.82% | |
| BGF World Healthscience A2 USD | reinvestment | 60.6900 | -5.78% | +31.25% | |
| BGF World Healthscience A2 EUR | reinvestment | 58.3500 | +7.60% | +42.94% |
Performance
| YTD | -10.20% | ||
|---|---|---|---|
| 6 Months | -8.58% | ||
| 1 Year | -6.77% | ||
| 3 Years | +25.79% | ||
| 5 Years | +50.26% | ||
| Since start | +102.40% | ||
| Year | |||
| 2021 | +13.49% | ||
| 2020 | +11.39% | ||
| 2019 | +22.97% | ||
| 2018 | +4.09% | ||
| 2017 | +22.30% | ||
| 2016 | -7.25% | ||
| 2015 | +6.50% | ||